Skip to main content
News
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Quarterly Results
SEC Filings
Governance
Governance Documents
Management
Board of Directors
Committee Composition
Contact
FAQ
Request Info
Email Alerts
Site Search
Search query
News
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Quarterly Results
SEC Filings
Governance
Governance Documents
Management
Board of Directors
Committee Composition
Contact
FAQ
Request Info
Email Alerts
Search query
News Releases
News
Events & Presentations
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Quarterly Results
SEC Filings
Governance
Governance Documents
Management
Board of Directors
Committee Composition
Contact
FAQ
Request Info
Email Alerts
Normal
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2014
2013
Nov 07, 2019
AbCellera Announces the Issuance of Foundational Patent Claims Around Microfluidic Screening Assays for Antibody Discovery
Download PDF
PDF format download (opens in new window)
Oct 31, 2019
Dr. Michael Hayden joins AbCellera’s Board of Directors
Download PDF
PDF format download (opens in new window)
Sep 27, 2019
AbCellera named one of Canada’s Top Growing Companies
Download PDF
PDF format download (opens in new window)
Sep 05, 2019
AbCellera Appoints Andrew Booth as Chief Financial Officer and Tryn Stimart as General Counsel
Download PDF
PDF format download (opens in new window)
Jun 13, 2019
AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease
Download PDF
PDF format download (opens in new window)
May 09, 2019
AbCellera Announces Partnership with NIAID Vaccine Research Center and Ichor Medical Systems to Tackle Pandemic Viral Outbreaks
Download PDF
PDF format download (opens in new window)
Mar 14, 2019
AbCellera Signs Agreement with Global Health Foundation to Fight Infectious Disease
Download PDF
PDF format download (opens in new window)
Feb 28, 2019
AbCellera and Denali Therapeutics Sign Expanded Multi-Year, Multi-Target Deal to Discover Therapeutic Antibodies for Neurological Diseases
Download PDF
PDF format download (opens in new window)
Feb 14, 2019
AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma
Download PDF
PDF format download (opens in new window)